Browse the evidence

Obesity is associated with significantly lower circulating levels of B-type natriuretic peptide (BNP) and N-terminal pro-atrial natriuretic peptide (N-ANP) compared to lean individuals, independent of hypertension and diabetes status.

If you are obese, your body's natural blood pressure-regulating hormones (BNP and ANP) are likely suppressed, which may contribute to higher blood pressure. This is not just about 'stress' on the heart; it involves how fat tissue clears these hormones. Weight loss may help restore these protective hormone levels.

Cardiovascular health, specifically arterial pulsatility driven by cardiac output, is a mechanical prerequisite for effective glymphatic fluid transport; conditions like hypertension and heart failure reduce this pulsatility, impairing waste clearance and increasing dementia risk.

Maintain cardiovascular health to support the mechanical force (arterial pulsatility) that drives brain waste clearance. Manage blood pressure, treat heart conditions, and stay physically active to ensure your heart pumps effectively, which in turn helps your brain clear out harmful proteins.

Mitochondrial dysfunction and the resulting accumulation of reactive oxygen species (ROS) are primary drivers of aging and age-related diseases, creating a vicious cycle of oxidative damage to mitochondrial DNA (mtDNA) and cellular energy depletion.

Aging is closely linked to mitochondrial health and oxidative stress. While you cannot stop ROS entirely (they are necessary for signaling), maintaining mitochondrial function through regular physical activity and a balanced diet is the most evidence-supported approach to mitigating age-related decline. Be skeptical of antioxidant supplements claiming to reverse aging, as clinical evidence for lifespan extension in humans is lacking.

Pericardial fat volume is independently associated with coronary artery calcification (CAC) even after adjusting for visceral abdominal fat (VAT), BMI, waist circumference, and metabolic risk factors, suggesting a local toxic effect on the vasculature.

If you have metabolic risk factors (like high blood pressure or glucose) but a normal BMI, standard weight checks might miss hidden heart risks. Pericardial fat, which surrounds the heart, is a specific predictor of coronary artery calcification. While not everyone needs a CT scan, understanding that 'normal weight' doesn't guarantee zero vascular risk is key. If you are undergoing cardiac imaging for other reasons, ask if pericardial fat volume was assessed, as it provides independent risk data beyond just waist size.

Biological aging, defined as the rate of physiological deterioration across multiple organ systems, can be quantified in young adults (ages 26-38) who are free of age-related chronic diseases, and this accelerated aging is associated with earlier physical, cognitive, and subjective health decline.

You can measure your biological age using validated biomarkers (like the 18-biomarker panel used in this study) even in your 30s. If your biological age is higher than your chronological age, it indicates faster physiological deterioration, which is linked to earlier cognitive and physical decline. This highlights the importance of early lifestyle interventions to slow this pace before chronic diseases develop.

NAD+ metabolism regulates physiological processes and its deficiency contributes to metabolic diseases, cancer, aging, and neurodegeneration.

Maintaining healthy NAD+ levels is crucial for preventing age-related diseases. While the paper focuses on mechanisms, lifestyle factors like exercise and caloric restriction are known to support NAD+ homeostasis. Consider discussing NAD+ precursors with a healthcare provider if you are interested in therapeutic interventions.

NAD+ deficiency contributes to a spectrum of diseases including metabolic diseases, cancer, aging and neurodegeneration disorders.

Maintaining healthy NAD+ levels is crucial for preventing age-related diseases. While the paper focuses on mechanisms, lifestyle factors like exercise and caloric restriction are known to support NAD+ homeostasis. Consider discussing NAD+ precursors with a healthcare provider if you are interested in therapeutic interventions.

Reducing total dietary fat to 30% or less of calories, and saturated fat to less than 10%, is unlikely to have a substantial, sustained effect on body fatness or breast cancer risk, although it may modestly reduce CHD mortality.

Don't expect that simply cutting fat to 30% of your calories will lead to significant long-term weight loss or breast cancer risk reduction. Focus on overall diet quality, including vegetables, fruits, and whole grains, rather than just fat percentage.

Insulin resistance in skeletal muscle is driven by intramuscular lipid accumulation interfering with insulin signaling, rather than by increased fat oxidation inhibiting glucose metabolism via the Randle cycle.

Insulin resistance in muscle is not caused by your body's ability to burn fat. Instead, it is linked to the buildup of specific fat molecules (like diacylglycerol and ceramide) inside muscle cells that block insulin signals. This happens when lipid accumulation exceeds the muscle's ability to oxidize or store it safely, often seen in obesity and type 2 diabetes. Focus on improving metabolic flexibility and reducing intramuscular lipid accumulation rather than fearing fat oxidation.

Metabolic inflexibility in insulin-resistant skeletal muscle is characterized by a failure to suppress lipid oxidation during insulin stimulation and a failure to increase lipid oxidation during fasting.

In insulin resistance, your muscles lose the ability to switch fuels efficiently. They fail to burn more fat when fasting and fail to switch to glucose when insulin is high. This 'metabolic inflexibility' leads to lipid accumulation. Improving this flexibility is a key goal for managing insulin resistance.

Ectopic lipid accumulation in the liver and skeletal muscle is a primary cause of insulin resistance, mediated by lipid metabolites like diacylglycerol (DAG) and ceramides which interfere with insulin signaling pathways.

Focus on reducing fat stored in your liver and muscles, not just overall weight. This can be achieved through modest weight loss, exercise, or specific medical treatments for conditions like NAFLD. Reducing intrahepatic triglycerides dramatically reverses insulin resistance.

Diacylglycerol (DAG) accumulation at the plasma membrane, specifically the sn-1,2 stereoisomer, activates Protein Kinase C (PKC) isoforms (PKCε in liver, PKCθ in muscle), which inhibits insulin signaling.

Not all fat is bad for insulin signaling. It is the specific type and location of fat (DAG at the cell membrane) that blocks insulin. Reducing this specific lipid fraction improves sensitivity.

The transition from metabolically healthy obesity (MHO) to metabolically unhealthy obesity (MUO) is common, with approximately 30-50% of MHO individuals developing metabolic abnormalities over 3-12 years.

Your 'healthy' metabolic status is not guaranteed to last. Studies show that 30-50% of people with MHO develop diabetes or heart risks within a decade. You should monitor your metabolic markers regularly and maintain physical activity to delay or prevent this transition.

High-throughput quantitative serum NMR metabolomics provides a cost-effective, automated method to profile over 200 molecular measures (lipoprotein subclasses, fatty acids, amino acids) from a single sample, enabling large-scale epidemiological risk assessment comparable to standard lipid measurements.

For researchers and clinicians, adopting high-throughput NMR metabolomics allows for the routine, cost-effective assessment of detailed metabolic health (lipoprotein subclasses, amino acids) from standard blood samples. This provides a more nuanced view of cardiovascular and metabolic risk than traditional lipid panels alone, without significantly increasing cost or complexity due to automation.

The association between ultra-processed food consumption and cancer risk is not mediated by standard nutritional factors like lipid, sodium, or carbohydrate intake.

This study suggests that the cancer risk associated with ultra-processed foods is not just because they are high in fat, sugar, or salt. Even when accounting for these nutritional factors, the risk persists. This implies that the processing methods, additives, and contaminants in these foods may play a significant role in increasing cancer risk, independent of their basic nutritional content.

Sleep restriction (4 hours/night) increases evening cortisol levels and delays the nocturnal nadir, while simultaneously decreasing TSH levels and amplitude, indicating a disruption of the hypothalamo-pituitary-adrenal and thyroid axes.

Short sleep doesn't just make you tired; it shifts your stress hormones (cortisol) to be higher in the evening and lowers thyroid-stimulating hormone (TSH). This hormonal imbalance contributes to metabolic stress. Prioritizing 8 hours of sleep helps normalize these rhythms.

Lower LDL-cholesterol levels causally protect against type-2 diabetes, which may explain the increased T2D risk observed with statin therapy.

If you are taking statins for cholesterol, be aware that they may slightly increase your risk of type-2 diabetes. Regular monitoring of blood sugar levels is advisable. Do not stop medication without consulting your doctor, as the cardiovascular benefits often outweigh this risk.

High body-mass index (BMI ≥25 kg/m²) is causally associated with an increased global burden of cancer, accounting for 3.6% of all new adult cancer cases in 2012, with the highest attributable fractions found in women and high human development index countries.

Maintaining a healthy body weight is a critical, modifiable factor in reducing your risk of several common cancers, particularly breast, colon, and endometrial cancers. This is not just about aesthetics; it is a direct public health measure. Aim for a BMI between 20-25 kg/m², as risk increases continuously with higher BMI values, even within the 'normal' range. This is especially important for women, who face a higher attributable fraction of cancer cases from high BMI compared to men.

Altered muscle composition, specifically lower muscle attenuation (indicative of intramuscular fat), is a strong independent marker of insulin resistance, particularly in obese individuals.

For those who are obese, the quality of your muscle matters as much as its size. Lower muscle density (attenuation) on CT scans, which reflects higher intramuscular fat, is a strong predictor of insulin resistance. Prioritize exercises and nutrition that improve muscle quality and reduce intramuscular fat, not just increasing muscle size.

Long-term hormone replacement therapy (estrogen/progestin) in postmenopausal women delays atherosclerosis and bone loss but increases the risk of breast cancer, with no clear impact on life expectancy.

For postmenopausal women, Hormone Replacement Therapy (HRT) is a trade-off: it significantly protects bones and heart health but increases breast cancer risk and does not extend life. The decision should be personalized based on individual risk factors, family history, and attitude toward treatment, rather than applied universally.

Vitamin D supplementation alone does not significantly increase bone mineral density or reduce the risk of fractures or falls in older people.

If you are an older adult taking Vitamin D supplements hoping to prevent falls or broken bones, know that current evidence does not support this specific benefit when taken alone. You should not stop taking it if prescribed for other reasons, but do not rely on it as a fall-prevention strategy. Focus on balance training and strength exercises instead.

Peripheral ghrelin increases food intake by binding to GHSR receptors in the ventral tegmental area (VTA), thereby increasing dopamine neuron firing rates and synaptic plasticity.

This research highlights that hunger is driven by a specific hormonal signal (ghrelin) that directly activates your brain's reward system (VTA). Understanding this biological mechanism can help shift the perspective from 'willpower' to managing biological signals, such as through scheduled eating or managing environmental cues that trigger these pathways.

Blocking GHSR receptors in the VTA attenuates rebound feeding after fasting and blunts the feeding response to restricted feeding schedules.

This finding suggests that the brain's reward system, specifically the VTA, plays a critical role in the 'catch-up' eating that happens after fasting. Blocking this specific pathway can reduce the intense urge to eat after a fast, highlighting the importance of the brain's reward circuitry in appetite regulation.

Obesity-induced chronic low-grade inflammation in adipose tissue acts as a causal mechanism for insulin resistance and type 2 diabetes mellitus.

In obesity, fat tissue doesn't just store energy; it actively releases inflammatory signals that block insulin from working. This inflammation is a key driver of type 2 diabetes risk. While weight loss helps, the inflammatory state itself is a direct cause of metabolic dysfunction, suggesting that managing inflammation is crucial for metabolic health.